Skip to main content

STIFEL FINANCIAL CORP

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 720672 ST. LOUIS, MO

Position in RYTM

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,408,859
+$335,737 QoQ
Shares Held
12,689
+2.8% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#147
of 299 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $537,727,692 across 104 Biotechnology names. RYTM ranks #38 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RYTM

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,408,859 12,689
2026-03-31 $1,073,122 12,339
2025-12-31 $1,417,958 13,247
2025-09-30 $1,459,809 14,455
2025-06-30 $1,148,604 18,177
2025-03-31 $979,255 18,487
2024-12-31 $1,092,504 19,516
2024-09-30 $1,039,522 19,842
2024-06-30 $1,152,060 28,058
2024-03-31 $1,210,509 27,937
2023-12-31 $1,407,831 30,625
2023-09-30 $1,054,320 45,990
2023-06-30 $770,017 46,696
2023-03-31 $383,381 21,490
2022-12-31 $564,345 19,380
2022-09-30 $479,710 19,580
2022-06-30 $78,688 18,961
2022-03-31 $303,736 26,366
2021-12-31 $737,651 73,913
2021-09-30 $1,757,692 134,586
2021-06-30 $3,552,085 181,414
2021-03-31 $2,493,545 117,233
2020-12-31 $346,472 11,654